Related Experiment Video
Updated: May 28, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions
Bo Young Nam1, Jisun Paeng, Seung Hye Kim
1Department of Internal Medicine, College of Medicine, Severance Biomedical Science Institute, Yonsei University, Seodaemoon-Gu, Seoul, Korea.
Abstract:
Previous studies have demonstrated the importance of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of diabetic nephropathy in terms of inflammation, but the direct role of the MCP-1/CCR2 system on podocyte apoptosis under diabetic conditions has never been explored. In vitro, mouse podocytes were exposed to a medium containing 30 mM glucose (HG) with or without CCR2 siRNA or CCR2 inhibitor (RS102895). Podocytes were also treated with MCP-1 or TGF-β1 with or without anti-TGF-β1 antibody, CCR2 siRNA, or CCR2 inhibitor. In vivo, 20 db/m and 20 db/db mice were divided into two groups, and ten mice from each group were treated with RS102895. Western blot and Hoechst 33342 or TUNEL staining were performed to identify apoptosis. HG-induced apoptosis and TGF-β1 levels were significantly abrogated by CCR2 inhibition. In addition, treatment with MCP-1 directly induced apoptosis via CCR2. Moreover, TGF-β1- and MCP-1-induced apoptosis were significantly ameliorated by the inhibition of CCR2 and anti-TGF-β1 antibody, respectively. Glomerular expression of cleaved caspase-3 and apoptotic cells within glomeruli were also significantly increased in db/db mice compared to db/m mice, and these increases were significantly attenuated in db/db + RS102895 mice. These results suggest that interactions between the MCP-1/CCR2 system and TGF-β1 may contribute to podocyte apoptosis under diabetic conditions.
Insights
The MCP-1/CCR2 system and TGF-β1 contribute to podocyte apoptosis in diabetic nephropathy. Inhibiting CCR2 reduces high glucose-induced cell death and TGF-β1 levels, suggesting a therapeutic target.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Diabetic nephropathy involves inflammation, with monocyte chemoattractant protein-1 (MCP-1) playing a key role.
- The direct impact of the MCP-1/CCR2 system on podocyte apoptosis in diabetes remains unclear.
Purpose of the Study:
- To investigate the role of the MCP-1/CCR2 system in high glucose-induced podocyte apoptosis.
- To explore the interplay between MCP-1/CCR2 and TGF-β1 in diabetic kidney disease.
Main Methods:
- In vitro studies using mouse podocytes exposed to high glucose, MCP-1, or TGF-β1, with CCR2 inhibition (siRNA or RS102895).
- In vivo studies using db/m and db/db mice treated with RS102895.
- Western blot and TUNEL staining to assess apoptosis and cleaved caspase-3 expression.
Main Results:
- CCR2 inhibition significantly reduced high glucose-induced podocyte apoptosis and TGF-β1 levels.
- MCP-1 directly induced apoptosis via CCR2; TGF-β1-induced apoptosis was also ameliorated by CCR2 inhibition.
- db/db mice showed increased glomerular apoptosis, which was attenuated by RS102895 treatment.
Conclusions:
- The MCP-1/CCR2 system, in conjunction with TGF-β1, contributes to podocyte apoptosis in diabetic conditions.
- Targeting the MCP-1/CCR2 pathway may offer a therapeutic strategy for diabetic nephropathy.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Diabetic Nephropathy
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Caspases
